Targeting Protein Misfolding Congress | Kisaco Research

Targeting Misfolding Protein Congress

Exploring modulation and stabilization of aberrant and misfolded proteins through targeted small molecule therapeutics

Download Agenda
Virtual Summit
15-17 March, 2021

The Targeting Misfolding Congress will be co-locating with the Targeting RNA Congress this year. Download the Targeting RNA Congress agenda to find out more

Why Attend

With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting time to be targeting misfolding diseases.

Though there are currently no therapies and cures in this area of drug discovery due to several unmet drug discovery needs. The inaugural Targeting Protein Misfolding Congress will bring together academic and industry leaders, such as Anavex, Ionis Pharmaceuticals, Wren Therapeutics, Ariona State University and University of Florida, who are building platforms to identify and validate targets in protein misfolding diseases and intrinsically disordered proteins to combat these challenges:

  • The lack of appropriate disease models, physiological assays and blood biomarkers to evaluate translation aspects and target engagement.
  • Delivery mechanisms to deliver small molecules and biologics across the blood brain barrier.
  • Determining the true drivers and toxic species in protein misfolding diseases. 
  • Mapping the druggable hotspots on protein aggregates and intrinsically disordered proteins to target with small molecules.

Key outcomes this year include:

  • Improve pre-clinical predictability by learning what disease models are now considered best practice with Beth Hoffman, Founder and CEO, Origami Therapeutics and understand how Pfizer develops physiologically relevant assays for phenotypic screening.
  • Understand the underlying chemical biology of protein aggregation and the drivers behind misfolding diseases to help inform your target validation with Peter Lansbury, CSO, Lysosomal Therapeutics
  • Learn about the latest developments in delivery of biologics across the blood brain barrier as well as viral delivery advancements with Laura Ranum, Professor, University of Florida
  • Target your aggregate of choice after hearing Behnam Nabet, Research Fellow, Dana Farber Cancer Institute discuss novel approaches involving degradation
100+
Attendees
20+
Leading Speakers
3
Days of sharing the latest developments

Who Attends

30%
Pharma
30%
Biotech
30%
Academic & Research Institutes
10%
Service Providers

Pharma

Biotech

Academic & Research Institutes

Service Providers

Speakers

 

Johanne Kaplan

CDO
ProMIS Neurosciences

Johanne Kaplan

CDO
ProMIS Neurosciences

Johanne Kaplan

CDO
ProMIS Neurosciences
 

Abhishek Singharan

Assistant Professor
School of Molecular Sciences, Arizona State University

Abhishek Singharan

Assistant Professor
School of Molecular Sciences, Arizona State University

Abhishek Singharan

Assistant Professor
School of Molecular Sciences, Arizona State University
 

Tiago Outeiro

Professor
Universität Göttingen

Tiago Outeiro

Professor
Universität Göttingen

Tiago Outeiro

Professor
Universität Göttingen
 

Jack Rogers

Associate Professor of Psychiatry
HMS

Jack Rogers

Associate Professor of Psychiatry
HMS

Jack Rogers

Associate Professor of Psychiatry
HMS
 

Alberto Perez

Assistant Professor
University of Florida

Alberto Perez

Assistant Professor
University of Florida

Alberto Perez

Assistant Professor
University of Florida
 

Laura Ranum

Professor
University of Florida

Laura Ranum

Professor
University of Florida

Laura Ranum

Professor
University of Florida
 

Fabien Vincent

Research Fellow
Pfizer

Fabien Vincent

Research Fellow
Pfizer

Fabien Vincent

Research Fellow
Pfizer
 

Peter Lansbury

Chief Scientific Officer
Lysosomal Therapeutics

Peter Lansbury

Chief Scientific Officer
Lysosomal Therapeutics

Peter Lansbury

Chief Scientific Officer
Lysosomal Therapeutics
 

Beth Hoffman

CEO and Founder
Origami Therapeutics

Beth Hoffman

CEO and Founder
Origami Therapeutics

Beth Hoffman

CEO and Founder
Origami Therapeutics
 

Gene Yeo

Professor of Cellular and Molecular Medicine
UCSD

Gene Yeo

Professor of Cellular and Molecular Medicine
UCSD

Gene Yeo

Professor of Cellular and Molecular Medicine
UCSD
 

Hien Zhao

Director of Neuroscience Research
Ionis Pharmaceuticals

Hien Zhao

Director of Neuroscience Research
Ionis Pharmaceuticals

Hien Zhao

Director of Neuroscience Research
Ionis Pharmaceuticals
 

Alexander Scheer

CSO
Aelin Therapeutics

Alexander Scheer

CSO
Aelin Therapeutics

Alexander Scheer

CSO
Aelin Therapeutics
 

Chris Missling

President & CEO
Anavex Life Sciences

Chris Missling

President & CEO
Anavex Life Sciences

Chris Missling

President & CEO
Anavex Life Sciences
 

Rick Morimoto

Professor
Northwestern University

Rick Morimoto

Professor
Northwestern University

Rick Morimoto

Professor
Northwestern University
 

Michele Vendruscolo

CSO
Wren Therapeutics

Michele Vendruscolo

CSO
Wren Therapeutics

Michele Vendruscolo

CSO
Wren Therapeutics
 

Judith Frydman

Professor
Stanford University

Judith Frydman

Professor
Stanford University

Judith Frydman

Professor
Stanford University
 

Gergely Toth

Founder and CEO
Cantabio

Gergely Toth

Founder and CEO
Cantabio

Gergely Toth

Founder and CEO
Cantabio
 

Mark Reed

Founder
Treventis

Mark Reed

Founder
Treventis

Mark Reed

Founder
Treventis
 

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Get access to 2 conferences for the price of 1!

The Targeting Protein Misfolding Congress is co-locating virtually with the Targeting RNA Congress in March this year! Book your place on the Targeting Protein Misfolding Summit and get full access to the Targeting RNA Congress's content. 

Key Speakers at the Targeting RNA include: 

  • Jay Schneekloth, Principle Investigator, NIH
  • Craig Blain, Associate Director of Biochemistry, Arrakis Therapeutics
  • Silvi Rouskin, Whitehead fellow, MIT
  • Amanda Garner, Associate Professor, University of Michigan
  • Matt Disney, Co-Founder and Professor, Expansion therapeutics and Scripps Research Institute
  • Gene Yeo, Professor of Cellular and Molecular Medicine UCSD

DOWNLOAD THE FULL AGENDA TO FIND OUT MORE 

Sponsors

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.